Cargando…

Urinary Exosomes of Patients with Cystic Fibrosis Unravel CFTR-Related Renal Disease

Background: The prevalence of chronic kidney disease is increased in patients with cystic fibrosis (CF). The study of urinary exosomal proteins might provide insight into the pathophysiology of CF kidney disease. Methods: Urine samples were collected from 19 CF patients (among those 7 were treated b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gauthier, Sebastien, Pranke, Iwona, Jung, Vincent, Martignetti, Loredana, Stoven, Véronique, Nguyen-Khoa, Thao, Semeraro, Michaela, Hinzpeter, Alexandre, Edelman, Aleksander, Guerrera, Ida Chiara, Sermet-Gaudelus, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554933/ https://www.ncbi.nlm.nih.gov/pubmed/32927759 http://dx.doi.org/10.3390/ijms21186625

Ejemplares similares

Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters
por: Chevalier, Benoît, et al.
Publicado: (2022)

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
por: Pranke, Iwona, et al.
Publicado: (2019)

Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2021)

Acting on the CFTR Membrane-Spanning Domains Interface Rescues Some Misfolded Mutants
por: Baatallah, Nesrine, et al.
Publicado: (2022)

An unexpected effect of TNF-α on F508del-CFTR maturation and function
por: Bitam, Sara, et al.
Publicado: (2015)

Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
por: Pranke, Iwona M., et al.
Publicado: (2017)

Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice
por: Saussereau, Emilie Lyne, et al.
Publicado: (2013)

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999)

Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons
por: Pranke, Iwona, et al.
Publicado: (2018)

New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation
por: Bitam, Sara, et al.
Publicado: (2021)

Author Correction: New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation
por: Bitam, Sara, et al.
Publicado: (2021)

Proteomic profiling of sweat in patients with cystic fibrosis provides new insights into epidermal homoeostasis
por: Cornet, Matthieu, et al.
Publicado: (2022)

A Novel Lipidomic Strategy Reveals Plasma Phospholipid Signatures Associated with Respiratory Disease Severity in Cystic Fibrosis Patients
por: Guerrera, Ida Chiara, et al.
Publicado: (2009)

Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice
por: da Cunha, Mélanie Faria, et al.
Publicado: (2022)

Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis
por: Simonin, Juliette, et al.
Publicado: (2019)

Author Correction: Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis
por: Simonin, Juliette, et al.
Publicado: (2019)

Unsolved severe chronic rhinosinusitis elucidated by extensive CFTR genotyping
por: Degrugillier, Fanny, et al.
Publicado: (2019)

β‐adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?
por: Zampoli, Marco, et al.
Publicado: (2022)

Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators
por: Fajac, Isabelle, et al.
Publicado: (2021)

The CF-CIRC study: a French collaborative study to assess the accuracy of Cystic Fibrosis diagnosis in neonatal screening
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2006)

Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial
por: Quittner, Alexandra, et al.
Publicado: (2015)

Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report.
por: Sermet-Gaudelus, I, et al.
Publicado: (1999)

Structural models of CFTR–AMPK and CFTR–PKA interactions: R-domain flexibility is a key factor in CFTR regulation
por: Siwiak, Marian, et al.
Publicado: (2011)

Unraveling the CFTR Function–Phenotype Connection for Precision Treatment in Cystic Fibrosis
por: Zemanick, Edith T., et al.
Publicado: (2019)

Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2018)

Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2023)

Profiling the response to lumacaftor‐ivacaftor in children with cystic between fibrosis and new insight from a French‐Italian real‐life cohort
por: Cornet, Matthieu, et al.
Publicado: (2022)

Characterization of two rat models of cystic fibrosis—KO and F508del CFTR—Generated by Crispr‐Cas9
por: Dreano, Elise, et al.
Publicado: (2019)

In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2007)

Elexacaftor/Tezacaftor/Ivacaftor Disrupts Respiratory Tract Development in a Murine Fetal Lung Explant Model
por: Lhuillier, Mickaël, et al.
Publicado: (2022)

Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway
por: Saint-Criq, Vinciane, et al.
Publicado: (2018)

Peroxiredoxin 6 Fails to Limit Phospholipid Peroxidation in Lung from Cftr-Knockout Mice Subjected to Oxidative Challenge
por: Trudel, Stéphanie, et al.
Publicado: (2009)

Dataset of differential lipid raft and global proteomes of SILAC-labeled cystic fibrosis cells upon TNF -α stimulation
por: Chhuon, C., et al.
Publicado: (2016)

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
por: Marsac, Charlotte, et al.
Publicado: (2021)

Proteomic Analysis of Nasal Epithelial Cells from Cystic Fibrosis Patients
por: Jeanson, Ludovic, et al.
Publicado: (2014)

Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors
por: Amico, Giulia, et al.
Publicado: (2019)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

Moving the Dial on Airway Inflammation in Response to Trikafta in Adolescents with Cystic Fibrosis
por: Lepissier, Agathe, et al.
Publicado: (2023)

Cystic Fibrosis, CFTR, and Colorectal Cancer
por: Scott, Patricia, et al.
Publicado: (2020)

Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study
por: Sermet-Gaudelus, I., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sjahe25ucirapbgg34h7ivaa9k